Visual outcomes, safety profile and morphometric response of optical coherence tomography biomarkers to ranibizumab biosimilar treatment in neovascular age-related macular degeneration: Real-world evidence

PURPOSE: The aim of this study was to evaluate the safety, efficacy, and morphological response of intravitreal ranibizumab biosimilar (Razumab) in neovascular age-related macular degeneration (n-AMD) up to 12 weeks. METHODS: Retrospective analysis of 20 eyes of n-AMD receiving 4 weekly intravitreal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelkar, Aditya S, Kelkar, Jai, Bolisetty, Mounika, Kelkar, Shreekant B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302301/
https://www.ncbi.nlm.nih.gov/pubmed/34011722
http://dx.doi.org/10.4103/ijo.IJO_2977_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302301/
https://www.ncbi.nlm.nih.gov/pubmed/34011722
http://dx.doi.org/10.4103/ijo.IJO_2977_20

Ejemplares similares